Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorTianjin Medical University
About this trial
To evaluate the potential usefulness of 68Ga/18F-Exendin 4 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various GLP-1R-related disease patients.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- 18F/68Ga-Exendin 4
Treatment groups
500 Participants
are divided into 1 treatment groupLocations
1Tianjin Medical University General Hospital300052, TianjinTianjin Municipality, China
Sponsors and collaborators
Tianjin Medical University
Lead sponsor
Tianjin Medical University General Hospital
Collaborator
Source ClinicalTrials.gov